CODX vs XOM · rev $3.9M vs P/E 24, rev $332.24B
Co-Diagnostics, Inc. Common Stock (CODX) versus Exxon Mobil Corp (XOM) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Exxon Mobil Corp (XOM) is a oil & gas integrated company listed on NYSE. It is led by Darren Woods.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported XOM revenue for 2025-12-31 was $332.24B. Net income was $28.84B. Revenue was down 5.0% from 2024-12-31 to 2025-12-31. XOM currently screens at market cap $583.36B and trailing P/E 23.7.
CODX currently screens at market cap $31.4M. XOM currently screens at market cap $583.36B and trailing P/E 23.7.
Not investment advice. Open the CODX and XOM stock pages for the full models.
Not investment advice.